[1] 薛芮, 范建高. 代谢相关脂肪性肝病新定义的国际专家共识简介[J]. 临床肝胆病杂志, 2020,36(6):1224-1227.
[2] Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps[J]. Hepatology, 2019,70(4):1457-1469.
[3] Wang Z, Xu M, Hu Z, et al. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index[J]. Menopause. 2015,22(6):667-673.
[4] Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: The role of adipose tissue, muscle and liv-er[J]. Nat Rev Endocrinol, 2021,17(1):47-66.
[5] 李瀚旻, 张六通, 邱幸凡, 等. 左归丸改善MSG-肝再生大鼠肝肾精血亏虚证的作用机制研究[J]. 湖北中医学院学报, 2001(4):30-33+3.
[6] 李瀚旻. 基于“补肾生髓成肝”的肝癌三级预防方案的构建与应用[J]. 中西医结合肝病杂志, 2015,25(6):369-372.
[7] Zhao BB,Li HM,Gao X,et al.The herbal compound "diwu yanggan" modulates liver regeneration by affecting the hepatic stem cell microenvironment in 2-acetylaminofluorene/partial hepatectomy ra-ts[J].Evid Based Complement Alternat Med, 2015,2015:468303.
[8] 万勇, 林云华. 从肾论治非酒精性脂肪性肝[J]. 光明中医, 2019,34(5):683-685.
[9] 蔡珊珊, 梁惠卿, 刘垚昱,等. 吴耀南从肝肾同源理论论治非酒精性脂肪性肝病经验介绍[J]. 新中医, 2020,52(9):199-201.
[10] Winn NC, Jurrissen TJ, Grunewald ZI, et al. Estrogen receptor-α signaling maintains immunometabolic function in males and is obli-gatory for exercise-induced amelioration of nonalcoholic fatty liver[J]. Am J Physiol Endocrinol Metab, 2019,316(2):e156-e167.
[11] Wang X, Lu Y, Wang E, et al. Hepatic estrogen receptor α improves hepatosteatosis through upregulation of small heterodimer partner[J]. J Hepatol, 2015,63(1):183-190.
[12] Hart-Unger S, Arao Y, Hamilton KJ, et al. Hormone signaling and fatty liver in females: Analysis of estrogen receptor α mutant mi-ce[J]. Int J Obes (Lond), 2017,41(6):945-954.
[13] Mauvais-Jarvis F, Le May C, Tiano JP, et al. The role of estrogens in pancreatic islet physiopathology[J]. Adv Exp Med Biol, 2017,1043:385-399.
[14] Kelly DM, Akhtar S, Sellers DJ, et al. Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse[J]. Endo-crine, 2016,54(2):504-515.
[15] 赵晨露, 赵文霞. 雌激素缺乏对绝经后女性非酒精性脂肪性肝病的影响[J]. 临床肝胆病杂志, 2021,37(7):1708-1712.
[16] Fujii H, Kawada N, Japan Study Group Of Nafld Jsg-Nafld. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease[J]. Int J Mol Sci, 2020,21(11):3863.
[17] Ambikairajah A, Walsh E, Cherbuin N. Lipid profile differences during menopause: A review with meta-analysis[J]. Menopause,2019,26(11):1327-1333.
[18] Palmisano BT, Zhu L, Stafford JM. Role of estrogens in the regulation of liver lipid metabolism[J]. Adv Exp Med Biol, 2017,1043:227-256.
[19] 吴瑞芝, 史惠蓉. 绝经妇女非酒精性脂肪肝病及绝经激素治疗的研究进展[J]. 中国计划生育和妇产科, 2018,10(3):20-22,31.
[20] Santos-Marcos JA, Rangel-Zuñiga OA, Jimenez-Lucena R, et al. Influence of gender and menopausal status on gut microbiota[J]. Maturitas, 2018,116:43-53.
[21] Acharya KD, Gao X, Bless EP, et al. Estradiol and high fat diet associate with changes in gut microbiota in female ob/ob mice[J]. Sci Rep, 2019,9(1):20192.
[22] 谢冰颖, 黄景文, 陈赛楠, 等. 补肾法对围绝经期综合征大鼠性激素及卵巢雌激素受体的影响[J]. 福建中医药, 2021,52(10):11-13,22.
[23] 项逸欣,黄雅兰,周敏等.左归降糖清肝方通过调控FoxO1/MTP/APOB信号通路改善2型糖尿病合并非酒精性脂肪肝糖脂代谢[J].中国中药杂志,2023,48(16):4438-4445.
[24] 吕宝伟, 冯春青, 孙建光. 补肾降浊饮对非酒精性脂肪肝大鼠胰岛素抵抗的影响[J]. 中国实验方剂学杂志, 2018,24(12):107-113.
[25] 高继龙. 补肾化浊方防治肾阴虚型非酒精性脂肪肝疗效观察及机制探讨[D].济南:山东中医药大学,2012.
[26] 孙晶晶, 陶艳艳, 王清兰, 等. 滋阴清热方治疗绝经后女性非酒精性脂肪性肝病的临床疗效观察[J]. 临床肝胆病杂志, 2012,28(3):179-182.
[27] 欧丽娜, 张建军,王林元,等.具有雌激素样作用的补肾阳药对脂代谢的影响[J]. 中国实验方剂学杂志, 2013,19(8):371-374.
[28] 王晓敏, 王建红, 邹志坚, 等. 菟丝子黄酮对去势雌性大鼠血脂和血管雌激素受体的影响[J]. 中成药, 2008(2):255-256.
[29] 高巳东, 邓洋洋, 王重一, 等. 淫羊藿苷与雌激素对大鼠骨髓间充质干细胞成骨分化的影响[J]. 中国骨质疏松杂志, 2022,28(2):174-177,191.
[30] 赵岩, 韩玲玲, 侯莹莹, 等. 淫羊藿醇提物对高脂血症模型小鼠的降血脂作用及其抗氧化活性[J]. 吉林大学学报(医学版), 2017,43(1):1-5.
[31] Hai Y, Zuo L, Wang M, et al. Icariin alleviates nonalcoholic fatty liver disease in polycystic ovary syndrome by improving liver fatty acid oxidation and inhibiting lipid accumulation[J]. Molecules. 2023,28(2):517.
[32] 谢琼,杜念龙,易宏锋.鹿茸多肽调节Nrf-2/HO-1/NF-κB信号通路减轻非酒精性脂肪肝大鼠小肠黏膜屏障损伤[J].中药材,2023(3):741-746.